最新情報

2021.10.04インフォメーション

【学会・ランチョンセミナー】12/8 11:45~ 第50回日本免疫学会学術集会

第50回日本免疫学会学術集会 (会期:2021年12月8日~10日)においてランチョンセミナーを共催します。
後日の録画配信はございませんので、ぜひ学会ご参加の際はご視聴下さい。

テクニカルセミナー T2
日時:12月8日(水) 11:45 -12:45
場所:奈良春日野国際フォーラム甍 Room D会場 (会議室3+4) 現地開催+ライブ配信 ※録画配信はありません

座長: 岡本 一男
(東京大学大学院医学系研究科 骨免疫学寄付講座 特任准教授)

演題:「TCR repertoire analysis reveals spatiotemporal responses of tumor-reactive T cell clones」

演者:上羽 悟史
(東京理科大学研究推進機構 生命医科学研究所 炎症・免疫難病制御部門 准教授)

要旨:Understanding how tumor-specific T cells are induced and maintained in a tumor-bearing host is essential for optimizing cancer immunotherapy with immune checkpoint inhibitors (ICIs). TCR repertoire analysis is a powerful tool to track tumor-reactive T cell induction and maintenance using TCR sequences as molecular barcodes. We have previously reported the results of treatment of tumor-bearing mice with an anti-CD4 depleting antibody, which acts as an ICI by removing CD4+ and Foxp3+ regulatory T cells, promoting proliferation of tumor-specific CD8+ T cells in tumor-draining lymph nodes (dLN), and inhibiting tumor growth by increasing tumor-infiltrating CD8+ T cells. TCR repertoire analysis of the dLN and tumors in individual mice revealed that each dLN and corresponding tumor share a significant proportion of CD8+ T cell clones. The number and total frequency of these overlapping clones increase significantly with ICI treatments such as anti-CD4, anti-PD-L1, and anti-CD4/PD-L1. Surprisingly, ICI treatments did not affect expansion of the top10 overlapping clones, but increased the total frequency of less prevalent overlapping clones, the degree of which correlated with the antitumor efficacy of the ICIs. These results suggest that mobilization and expansion of diverse tumor-reactive clones contribute to the anti-tumor effect of ICIs. I will here introduce the potential of TCR repertoire analysis for investigating spatiotemporal responses of tumor-reactive T cell clones in clinical and pre-clinical studies.

発表言語:日本語

ご案内ポスター: こちらからダウンロード

一覧へ戻る